Accretive Health, Inc. Stock price Nyse
Equities
US00438V1035
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Mar. 21 | North American Morning Briefing : Investors -2- | DJ |
Mar. 21 | News Highlights : Top Financial Services News of the Day - Thursday at 12 AM ET | DJ |
Financials (USD)
Sales 2024 * | 2.64B | Sales 2025 * | 2.95B | Capitalization | 5.41B |
---|---|---|---|---|---|
Net income 2024 * | -3M | Net income 2025 * | 130M | EV / Sales 2024 * | 2.75 x |
Net Debt 2024 * | 1.84B | Net Debt 2025 * | 1.62B | EV / Sales 2025 * | 2.38 x |
P/E ratio 2024 * |
-763
x | P/E ratio 2025 * |
58.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 34.91% |
Latest transcript on Accretive Health, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Lee Rivas
CEO | Chief Executive Officer | - | 22-06-21 |
Director of Finance/CFO | - | 22-06-20 | |
John Sparby
PSD | President | 48 | 03-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Tersigni
BRD | Director/Board Member | 74 | 19-08-11 |
David M. Dill
BRD | Director/Board Member | 55 | 21-04-17 |
Joseph Flanagan
BRD | Director/Board Member | 52 | 13-03-31 |
1st Jan change | Capi. | |
---|---|---|
+1.01% | 99.96B | |
+23.22% | 87.73B | |
+10.42% | 29.33B | |
-3.88% | 18.21B | |
-3.46% | 14.51B | |
+19.69% | 12.22B | |
+31.78% | 12B | |
+0.17% | 11.94B | |
-12.00% | 11.63B |
- Stock
- Equities
- Stock R1 RCM Inc.
- Stock Accretive Health, Inc. - Nyse